AbbVie Inc.: accounts_receivable
| Value | {"amount": 12479000000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2026-03-31) |
| Status | current |
| Entity | AbbVie Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T15:44:40.562984+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/2d6a1441-87a1-4a3f-8235-8618873b236f
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001551152-26-000017Retrieved: 2026-08-19T15:44:40.562984+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001551152/accounts-receivable/2026-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/2d6a1441-87a1-4a3f-8235-8618873b236f
History
- no predecessors — first report